EPISODE · Oct 20, 2025 · 34 MIN
From Patents to Public Health: The GLP-1 Journey
from CPHI Podcast Series
In this insightful episode, host Lucy Chard is joined by Aurelio Arias from IQVIA to explore the transformative role of GLP-1 therapies in clinical obesity treatment and the technological advancements driving their success. Aurelio delves into how these medications are revolutionising care, offering hope to millions worldwide. A key focus is the upcoming patent expiry of semaglutide in 2026, which could significantly impact affordability and global access, sparking discussions on equitable distribution.
NOW PLAYING
From Patents to Public Health: The GLP-1 Journey
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m